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Abstract
Introduction. Pressure measurements obtained before and after hemodialysis (HD) are marked by their high varia-
bility and poor reliability, which undermine their ability to estimate cardiovascular events (CVs).
Objective. This study sought to determine whether more measurements performed over a longer period of time 
enable a more accurate evaluation of the CVs associated with arterial hypertension.
Material and methods. This study included 40 patients (23 men and 17 women) aged between 27 and 82 years 
with a mean age of 58.8 ± 13.6 years who underwent chronic HD for 4 to 338 months. On days without HD, blood 
pressure home measurements (HMs) were recorded in the morning, afternoon and evening, and the results were 
obtained each day for 8 days. Furthermore, pressure measurements were recorded five times during 7 subsequent 
planned HD procedures: before HD, after HD and three times during HD. After 12 months, the number of CVs 
was determined with respect to the pressure measurement method.
Results. The correlation coefficients between the HMs and HD with regard to systolic blood pressure (SBP), dias-
tolic blood pressure (DBP) and mean arterial pressure (MAP) were 0.85, 0.80, and 0.84, respectively (P < 0.001). 
The receiver operating curve (ROC) values for SBP were 137.8 mmHg for HM and 140.4 mmHg for HD. The 
sensitivity and specificity of the HMs for SBP were 0.667 and 0.727, respectively. CVs occurred in 66.7% of the 
patients with SBPs ≥ 137.8 mmHg. The sensitivity and specificity of the HD measurements of SBP were 0.611 and 
0.818, respectively. CVs occurred in 73.3% of patients with SBPs ≥ 140.4 mmHg.
Conclusions. Increasing the number of pressure measurements over a longer period of time in patients with HD 
likely improves the reliability of CV risk estimates. 
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Background
In the general population, the diagnosis of arterial 
hypertension and the assessment of the related car-
diovascular risks are based on precisely defined and 
commonly accepted principles pertaining to the con-
ditions and methods of blood pressure measurement 
[1]. Unfortunately, similar uniform principles have 
not been established for blood pressure measure-
ments in chronically hemodialyzed patients. Pres-
sure values obtained from pre- and post-hemodialysis 
(HD) measurements are marked by their high varia-
bility and poor reliability, which undermines their 
usefulness in individual patient prognosis [2–4].
Nevertheless, the blood pressure values recorded 
from measurements performed during HD, evalua-
ted in conjunction with readings from pre- and post-
-HD measurements, are highly consistent with the 
“gold standard” (i.e., 44-hour ambulatory blood pres-
sure monitoring) [5]. Therefore, the blood pressure 
values obtained from peridialytic measurements (be-
fore, after and during dialysis) should be recognized 
as advantageous and of a higher prognostic value. 
Increasing the number of measurements performed 
at a dialysis unit throughout a single treatment and 
repeating them over subsequent treatments enables 
a more accurate estimation of hypertension-related 
cardiovascular risk. When evaluating the agreement 
between home measurements (HMs) and the “gold 
standard” (i.e., 44-hour ambulatory blood pressure 
monitoring performed between subsequent dialyses), 
the advantage of HMs over peridialytic measure-
ments must be indicated [6, 7]. The high reliabi-
lity of HMs validates their considerable usefulness 
with regard to estimating the risk for cardiovascular 
complications [3, 8]. Thus, the application of this 
method of measurement, which is comparable with 
ambulatory measurements, encourages the undertak-
ing of additional trials in which pressure readings are 
taken over a longer period of time than previous re-
ports [3, 5]. Studies performed to date have involved 
pressure HMs over a one-week period. Furthermore, 
extending this period will likely improve the validity 
and reliability of the obtained results [8].
The current study assumes that HMs taken over 
a longer period of time, as well as pressure readings 
taken before, after and during HD (i.e., peridialytic 
measurements), would meet the above requirements. 
An additional advantage of HMs is that the patient 
is personally committed to the treatment process, 
which increases the effectiveness of therapy [9]. On 
the other hand, HMs might be unavailable to certain 
chronically hemodialyzed patients. For this group, 
one alternative solution is blood pressure monitoring 
based on the peridialytic measurements taken by the 
dialysis unit staff. 
The present study sought to determine:
1. the agreement between the blood pressure values 
obtained from peridialytic recordings and HMs and
2. the applicability of peridialytic recordings and 
HMs in estimating the risk of cardiovascular 
complications within 12 months based on the 
pressure measurements taken over two weeks 
among patients receiving chronic HD treatment. 
Material and methods
Material
The Bioethics Committee at the Nicolaus Coperni-
cus University Collegium Medicum in Bydgoszcz 
approved the study protocol (permission no. KB 
622/2011). All of the patients included in this study 
signed their written agreement for participation.
The study included 40 patients (23 men and 17 
women) aged between 27 and 82 years, with a mean 
age of 58.8 ± 13.6 years. These patients received 
chronic HD treatment for 4 to 338 months (median, 
27 months). The patient inclusion criteria were writ-
ten agreement for participation, age over 18 years, 
dialysis treatment received for at least 3 months, and 
unchanged type/dose of antihypertensive drugs for at 
least 2 weeks prior to inclusion (Table I). 
Sixteen patients had diabetes mellitus, and 23 
patients had a residual diuresis (57.5%) between 100 
mL and 2,800 mL, with a mean volume of 1,015 ± 
± 780 mL. Five patients did not receive any high 
blood pressure medication. The remaining patients 
received 1 to 6 medications across different drug 
groups. The most common option was the use of 2 or 
3 drugs, and the most common group of drugs was 
b-blockers (27 patients).
Methods
Prior to commencing the study, the patients were 
instructed with regard to recording their own blood 
pressure. First, they were familiarized with the opera-
tion of the automatic blood pressure monitor used 
for this study. They were asked to take their readings 
after a five-minute rest. The measurement was taken 
in a sitting position, with the cuff placed around the 
arm without vascular access and at the level of the 
heart. If a patient was unable to take their blood pres-
sure without assistance, then the family member pro-
viding care to the patient was included in this study. 
The patients or their family member performed 
blood pressure measurements on days without 
arterial hypertension 2017, vol. 21, no. 1
44 www.ah.viamedica.pl
Table I. Sample characteristics
Mean ± SD Median Minimum Maximum
Body weight [kg] 72.7 ± 13.3 46.0 110.0
Dialysis therapy time [months] 33 3 96
BMI [kg/m2] 25.8 ± 4.2 17.5 35.6
CRP [mg/L] 4.27 0.26 103.77
Albumin [µmol/L] 565.1 ± 52.2 405.7 666.5
Creatinine [µmol/L] 658.6 ± 2.47 315.6 1,131.5
PTH [ng/L] 303 6 1,900
Tsat% 37.9 ± 20.5 14.0 95.1
Hemoglobin [mmol/L] 6.9 ± 0.78 4.7 8.4
Kt/V 1.38 ± 0.18 0.83 1.67
Phosphate [mmol/L] 1.49 0.69 3.61
Iron [µmol/L] 14.9 ± 7.5 15.5 121.0
TIBC [µmol/L] 37.4 ± 7.2 22.7 51.7
Total cholesterol [mmol/L] 4.3 ± 1.2 2.0 7.4
HDL cholesterol [mmol/L] 1.0 ± 0.3 14.6 2.0
LDL cholesterol [mg/dL] 2.3 ± 0.8 0.5 4.6
Triglycerides [mg/dL] 2.1 0.5 5.8
Data are presented as means ± SDs unless otherwise stated. CRP — C-reactive protein; PTH — parathormone; Tsat% — transferrin saturation; Kt/V — HD treatment adequacy; TIBC — total iron binding capacity
dialysis, in the morning (7:00–8:00 am), after-
noon (2:00–3:00 pm) and evening (9:00–10:00 
pm), and the results were obtained for 8 days. 
Pressure readings were taken three times through-
out the day. The morning measurements were 
taken as the mean of three morning measure-
ments; the afternoon measurements were taken 
as the mean of three afternoon measurements; 
and the evening measurements were taken as the 
mean of three evening measurements.
The mean blood pressure HMs were calculated as 
the arithmetic mean of the morning, afternoon and 
evening readings. All blood pressure measurements 
were taken using the UA-631 A&D blood pressure 
monitor, A& D Medical, Kitamo, Japan. 
At the dialysis unit, the readings were taken during 
7 subsequent planned HD treatments. During one 
treatment, the nursing staff recorded the blood pres-
sure readings five times: before HD, three times 
during HD (every hour) and immediately after HD. 
All blood pressure measurements were taken using an 
attested device integrated with the B Braun Dialog 
Plus dialysis machine. 
The means of the subsequent measurements taken 
during HD were calculated as the arithmetic mean 
of the readings obtained from the 7 dialysis periods.
MAP (mean arterial pressure) =  
= DBP (diastolic blood pressure) + 1/3 pulse pressure
Pulse pressure = SBP (systolic blood pressure) – DBP 
The patients were then observed over 12 months 
to evaluate the occurrence of new cardiovascular 
events (CVs) or the aggravation of the previously 
diagnosed CVs.
Statistics
The normality of the variable distributions were ana-
lyzed using the Shapiro-Wilk test. In the case of var-
iables with approximately normal distributions, the re-
sults were presented as means and standard deviations 
(SDs), and these means were compared using Student’s 
t-test for independent and dependent variables as well 
as repeated-measures analyses of variance followed by 
Tukey’s post hoc test. For variables whose distribution 
deviated from normal, the results were presented as 
medians and ranges, and significant differences between 
groups were determined using the Mann-Whitney 
U test for independent variables. Group proportions 
were analyzed using the chi-square (c2) test; correlations 
between variables were determined using Pearson’s cor-
relation coefficient; and the agreement between mea-
surements was analyzed using a Bland-Altman plot.
Renata Naruszewicz, Jacek Manitius Intradialytic blood pressure and survival
45www.ah.viamedica.pl
To find the best parameters and optimal cut-off 
value, receiver operating curves (ROCs) were plot-
ted, and the area under the curve (AUC) was cal-
culated. To determine the prognostic value of the 
obtained cut-off values, the sensitivity, specificity, 
positive and negative predictive values, accuracy and 
likelihood ratio (LR) were calculated. The positive 
predictive value was calculated as the quotient of the 
number of patients correctly classified by the test 
over the group of patients with aggravated disease 
symptoms plus the total number of patients with 
positive results. The negative predictive value was 
calculated as the quotient of the number of patients 
correctly classified by the test over the group of pa-
tients without aggravated disease symptoms plus the 
total number of patients with negative results. Ac-
curacy was calculated as the quotient of the sum of 
the number of patients correctly classified by the test 
over the group of patients with aggravated disease 
symptoms and the patients correctly classified by the 
test over the group of patients without aggravated 
disease symptoms plus the total number of patients. 
The LR was calculated as the quotient of sensitivity 
over 1-specificity.
The significance level was set at P = 0.05. All cal-
culations were performed using Statistica v.10.0 PL 
(StatSoft, Inc.).
Results
Figure 1 presents the relationship between the ul-
trafiltration volume achieved during each HD treat-
ment and the body weight gain after each dialysis. 
The data show that changes in body weight caused 
by the accumulation of water between treatments 
were regularly and adequately removed during HD.
The mean HM and dialysis unit blood pressure read-
ings and their relationships are presented in Table II 
and Figures 2A-C, respectively. Figure 3A-C presents 
the Bland-Altman plots of the mean differences in 
the SBP, DBP and MAP values obtained from the 
HM and dialysis unit readings. Table III presents 
the results of the analysis using the Bland-Altman 
method. The mean differences between the HM and 
dialysis unit pressure values were not significant; 
therefore, a lack of agreement exists between those 
two clinical measurements.
At the beginning of the observation, CVs were diag - 
nosed in 34 patients from the study group, and the 
most frequent condition was chronic heart failure. In 
32 patients, chronic heart failure co-occurred with 
other conditions related to cardiovascular diseases. 
After 12 months of observation, aggravation of the 
initially diagnosed conditions or the occurrence of 
new symptoms was found in 18 patients (see Fig. 4).
No significant differences were found between 
patients diagnosed with CVs at the beginning of 
the 12-month observation and those without such 
complications with regard to the SBP, DBP or MAP 
means. This lack of differences pertained to the pres-
sure values obtained from both the HM and dialysis 
unit readings (data not presented).
Similarly, no differences were found between these 
groups in terms of the Kt/V, volume of ultrafiltration 
or body weight gain when the dialyses were expressed 
as percentages over the same period of observation 
(data not presented).
Higher SBP values were found among patients diag- 
nosed with aggravations to their initially diagnosed 
conditions or new cardiovascular symptoms after 
12 months, regardless of the measurement method 
(Table IV).
ROC curves were plotted to evaluate the applica-
bility of MAP regarding the estimation of the likeli-
hood of CVs. The ROC analysis enables the determi-
nation of the optimal analyzed blood pressure cut-off 
values that best divide a given group into a subgroup 
with a higher risk of complications and a subgroup 
Table II. Mean HM blood pressure values and those taken at  
a dialysis unit
HM Dialysis unit 
measurement
P value
Mean ± SD Mean ± SD
SBP [mmHg] 136.9 ± 21.4 133.4 ± 18.3 0.0537
DBP [mmHg] 73.6 ± 12.1 72.3 ± 8.5 0.2717
MAP [mmHg] 94.8 ± 12.8 92.7 ± 10.6 0.0681
Data are presented as means ± SDs. SBP — systolic blood pressure; DBP — diastolic blood pressure; 
MAP — mean arterial blood pressure
Figure 1. Correlation between the mean body weight gain and 
mean UF volume over two weeks 
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Figure 2. Correlation between the mean SBP and DBP values 
obtained from measurements taken at a dialysis unit and the same 
values obtained from HMs
Figure 3. Difference between MAP values based on HM and dialy-
sis unit measurements as a function of their means
Table III. The agreement between HMs values and those taken at a dialysis unit using the Bland-Altman plot
Mean difference [mmHg]
(95% confidence intervals)
p value Reliability coefficient
(2 x SD)
Limits of agreement
Lower Upper
SBP –3.5 (–7.1; 0.1) 0.0537 22.4 -–25.9 18.9
DBP –1.3 (–3.7; 1.1) 0.2717 14.8 –16.1 13.5
MAP –2.0 (–4.2; 0.2) 0.0681 13.8 –15.8 11.8
SBP — systolic blood pressure; DBP — diastolic blood pressure; MAP — mean blood pressure
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Figure 4. Course of cardiovascular complications over a 12-month observation period
Table IV. Mean HM blood pressure values and those taken at a dialysis unit among patients with and without aggravated disease  
symptoms
Mean ± SD HM Dialysis unit measurement p value
Mean ± SD
Without aggravation 
of symptoms
N = 22
SBP [mmHg] 128.5 ± 15.6 128.1 ± 16.6 0.8267
DBP [mmHg] 71.4 ± 12.8 71.2 ± 8.7 0.8996
MAP [mmHg] 90.4 ± 11.7 90.2 ± 9.4 0.8393
With 
aggravation 
of symptoms 
N = 18
SBP [mmHg] 147.2 ± 23.5 140.0 ± 20.1 0.0178
DBP [mmHg] 76.4 ± 11.0 73.7 ± 8.2 0.1841
MAP [mmHg] 100.1 ± 12.4 95.9 ± 11.4 0.0234
Data are presented as means ± SDs. SBP — systolic blood pressure, DBP — diastolic blood pressure, MAP — mean blood pressure
with a lower risk of complications. Moreover, the 
AUC was calculated for the analyzed pressure values 
and obtained cut-off points. Table V presents the 
cut-off points and AUCs. The AUCs for SBP and 
MAP were higher concerning HMs than in those 
taken at a dialysis unit. The highest AUC values ex-
ceeding 0.7 applied to the SBP values obtained from 
HMs at a cut-off value of 137.8 mmHg and to the 
MAP values obtained from HMs at a cut-off value 
of 94.9 mmHg (Table V). Complications occurred 
in patients more often for the SBP cut-off point 
based on HMs of > 137.8 mmHg (66.7%) than for 
the SBP of < 137.8 mmHg (27.3%; P < 0.01). In 
addition, HMs revealed more frequent complications 
regarding MAP values > 94.9 mmHg (68.4%) than 
MAP values < 94.9 mmHg (23.8%; P < 0.005). For 
SBP values obtained from readings taken at a dialysis 
unit, complications occurred in 73.3% of cases for 
arterial hypertension 2017, vol. 21, no. 1
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Table V. Predictive blood pressure values at a given cut-off 
Parameter
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LR
SBP at home 137.8 0.740 0.667 0.727 0.700 0.667 0.727 2.4
SBP at a dialysis unit 140.4 0.692 0.611 0.818 0.720 0.733 0.720 3.4
DBP at home 78.6 0.619 0.389 0.773 0.600 0.583 0.607 1.7
DBP at a dialysis unit 75.4 0.592 0.389 0.818 0.625 0.636 0.621 2.1
MAP at home 94.9 0.737 0.722 0.727 0.725 0.684 0.762 2.6
MAP at a dialysis unit 101.7 0.649 0.389 0.955 0.700 0.875 0.656 8.6
PP at home 54.6 0.689 0.722 0.591 0.650 0.591 0.722 1.8
PP at a dialysis unit 55.1 0.684 0.778 0.591 0.675 0.609 0.765 1.9
SBP — systolic blood pressure, DBP — diastolic blood pressure, MAP — mean blood pressure, PP — pulse pressure; LR — likelihood ratio
the cut-off value > 140.4 mmHg, a frequency that 
was significantly higher (P < 0.005) than the cut-off 
of < 140.4 mmHg.
Discussion
A new conclusion of major clinical importance 
drawn from the present study is that it is possible 
to estimate the direction of changes in blood pres-
sure values during the interdialytic period based on 
two-week-long peridialytic measurements. Hence, 
two-week peridialytic measurements can reflect the 
direction of changes in blood pressure when HMs 
are unavailable to a patient. 
This study did not reveal significant differences 
between the readings taken using different measure-
ment methods or high-positive linear correlation 
coefficients between these methods. Our results al-
lowed us to formulate the aforementioned conclu-
sions, indicating the applicability of an alternative 
method to HMs for taking the blood pressure of 
hemodialyzed patients. Importantly, however, this 
high comparability between blood pressure values 
was achieved not only by increasing the number of 
measurements itself but also by extending the period 
during which they were taken. The results of the 
present study are comparable with those obtained 
in studies in which the median of all peridialytic 
measurements was used instead of their mean [10]. 
Moreover, given that peridialytic measurements 
might constitute an alternative to HMs and con-
sidering the findings of other authors, the current 
method may be applicable for monitoring the treat-
ment of arterial hypertension [11].
The present study determined the optimal pressure 
values by dividing the study group into a subgroup 
with a higher risk of cardiovascular complications 
and a subgroup with a lower risk of complications 
based on the ROC analysis. The analysis of the ROCs 
and AUCs (Table V) indicates that the best para-
meter for differentiating the study group in terms 
of CVs is the SBP from HMs (cut-off point, 137.8 
mmHg) and the SBP from dialysis unit recordings 
(cut-off point, 140.4 mmHg). The sensitivity of the 
SBP values from HMs was 0.667, and the specificity 
was 0.727. CVs occurred in 66.7% of patients with 
SBP values ≥ 137.8 mmHg (positive predictive va-
lue). The sensitivity of the SBP values from dialysis 
unit measurements was 0.611, and the specificity was 
0.818. CVs occurred in 73.3% of patients with SBP 
values ≥ 140.4 mmHg (positive predictive value). 
Thus, both blood pressure measurement methods are 
equally applicable for determining the critical blood 
pressure values regarding clinical CVs. Our findings 
reveal the predominant role that SBP plays in the de-
velopment of organ-specific complications [12, 13].
The aforementioned observational studies were 
supplemented by data that enabled the identification 
of correlations between left ventricular hypertrophy 
and the SBP values obtained from HMs [14, 15]. 
Nevertheless, the data analysis presented in Table V 
indicates a limit to the applicability of the pressure 
readings with regard to predicting the occurrence 
of complications, regardless of the measurement 
method used. The sensitivity and specificity values 
demonstrate that approximately 1/3 of patients with 
SBP values above the cut-off will not experience 
complications, whereas approximately 1/3 of patients 
with SBP values below the cut-off will experience 
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complications. Similar values in terms of specificity 
were obtained in a study that analyzed sensitivity 
and specificity with respect to the left ventricular 
hypertrophy and HMs [15]. In that case, the data 
cast considerable doubt regarding the theory that 
blood pressure is a cause of CVs among chronical-
ly hemodialyzed patients. This finding might result 
from the role that arterial hypertension plays a role in 
the pathogenesis of malleable complications. Hyper-
tension seems to have a significantly more negative 
effect on the development of complications among 
patients who have just begun treatment than in those 
who receive long-term dialysis [16]. 
Considering the additional conclusions drawn 
from this analysis, it must be indicated that the cut-
-off value above which the risk for complications 
increases remained undetermined for approximate-
ly 20–30% of the patients included in the present 
study, regardless of the measurement method used 
(HM vs. peridialytic). This unknown implies the 
need for further studies.
Despite the above results, the limitations of the 
present study must be discussed.
A small sample size hinders a more thorough sta-
tistical analysis and the generation of more reliable 
results. Importantly, the current study was performed 
among patients who received treatment at only one 
dialysis unit. Given that, this sample significantly 
changed over one year because of possible kidney 
transplantation and, in some cases, death, and it was 
difficult to include a sufficient number of patients in 
this study. The study group was also heterogeneous 
in terms of the overall duration of HD in individual 
patients as well as with regard to their age. These 
facts, coupled with the small sample size, increase 
the difficulty of providing a conclusive evaluation of 
the results.
A vast majority of the patients received antihy-
pertensive drugs. As such, the current results should 
be interpreted cautiously because they do not reflect 
the true relationship between blood pressure and 
its related complications. Importantly, the results of 
previous studies were also limited in this regard.
The evaluation of CVs was based solely on clinical 
manifestations and is therefore somewhat subjec-
tive. Undoubtedly, clinical assessments that include, 
for example echocardiography, would provide much 
more information, thereby enabling more possibili-
ties to interpret the results. Unfortunately, we have 
decided not to use the echo test because of its limited 
availability.
The blood pressure readings obtained via HMs 
should be assumed to contain an undetermined 
amount of error. The simultaneous use of 44-hour 
ambulatory blood pressure monitoring would allow 
us to verify the data obtained.
Furthermore, blood pressure measurement itself 
challenges the reliability of the current results be-
cause it was limited to one arm due to the presence 
of vascular access on the other, which made it impos-
sible to compare the results across both arms.
In conclusion, increasing the number of mea-
surements during HD and extending the period 
during which they are taken enables the evaluation 
of the pressure changes that occur between dia-
lyses and the related cardiovascular complications 
at a level comparable with that of between-dialysis 
HMs. The proposed method for taking measure-
ments during dialysis might constitute a valuable 
alternative to HMs in cases in which the latter is 
impossible.
Pressure values obtained from measurements be-
fore or after HD are marked by high variability and 
poor reliability, which undermine their ability to es-
timate cardiovascular risk. Therefore, the total perid-
ialytic results obtained before, after and during HD 
are more suitable, and more measurements recorded 
over a longer period of time should enable a more ac-
curate evaluation of the cardiovascular risk associated 
with arterial hypertension.
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